Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 67014-36-2 | MDL No. : | MFCD02684428 |
Formula : | C8H9N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZCXIPVIGYBHUTQ-UHFFFAOYSA-N |
M.W : | 163.18 | Pubchem ID : | 352271 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 48.29 |
TPSA : | 74.67 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.12 cm/s |
Log Po/w (iLOGP) : | 1.02 |
Log Po/w (XLOGP3) : | 0.25 |
Log Po/w (WLOGP) : | 0.75 |
Log Po/w (MLOGP) : | 0.58 |
Log Po/w (SILICOS-IT) : | 1.87 |
Consensus Log Po/w : | 0.9 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.56 |
Solubility : | 4.45 mg/ml ; 0.0273 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.38 |
Solubility : | 6.82 mg/ml ; 0.0418 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.84 |
Solubility : | 0.237 mg/ml ; 0.00146 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.53 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 5400-75-9 ]
5-Methyl-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.96
[ 221289-88-9 ]
2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbonitrile
Similarity: 0.84
[ 66655-67-2 ]
3,4-Dihydroquinazolin-2(1H)-one
Similarity: 0.81
[ 53439-88-6 ]
5-Amino-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.79
[ 54732-89-7 ]
5-Amino-1-methyl-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.79
[ 53439-88-6 ]
5-Amino-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.79
[ 517918-82-0 ]
1-(3-Aminophenyl)-3-methylimidazolidin-2-one
Similarity: 0.74
[ 85095-61-0 ]
N,N'-(Methylenebis(4,1-phenylene))bis(2,2-dimethylhydrazinecarboxamide)
Similarity: 0.69
[ 5400-75-9 ]
5-Methyl-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.96
[ 221289-88-9 ]
2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbonitrile
Similarity: 0.84
[ 54732-89-7 ]
5-Amino-1-methyl-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.79
[ 53439-88-6 ]
5-Amino-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.79